Risk of Squamous Cell Carcinoma and Methoxsalen (Psoralen) and UV-A Radiation (PUVA)
Open Access
- 1 December 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 134 (12) , 1582-1585
- https://doi.org/10.1001/archderm.134.12.1582
Abstract
Research from JAMA Dermatology — Risk of Squamous Cell Carcinoma and Methoxsalen (Psoralen) and UV-A Radiation (PUVA) — A Meta-analysisKeywords
This publication has 13 references indexed in Scilit:
- PUVA photocarcinogenesis in CheshireClinical and Experimental Dermatology, 1997
- Cutaneous neoplasia following PUVA therapy for psoriasisBritish Journal of Dermatology, 1996
- The carcinogenic risk of treatments for severe psoriasisCancer, 1994
- PUVA and cancer: a large-scale epidemiological studyThe Lancet, 1991
- "High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancerBritish Journal of Dermatology, 1991
- Non-Melanoma Skin Cancer Occurring in Patients Treated With PUVA Five to Ten Years After First TreatmentJournal of Investigative Dermatology, 1988
- Modern epidemiology?Journal of Epidemiology and Community Health, 1988
- A GENERAL ESTIMATOR FOR THE VARIANCE OF THE MANTEL HAENSZEL ODDS RATIOAmerican Journal of Epidemiology, 1986
- Cutaneous Squamous-Cell Carcinoma in Patients Treated with PUVANew England Journal of Medicine, 1984
- Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet LightNew England Journal of Medicine, 1974